When Measles Strikes: Exposure, Treatment, and Public Health Response
This is the final article in our three-part series on measles. In this installment, we explore what happens when measles cases occur, how exposures are managed, treatment options, and the coordinated public health response that helps protect our communities.
When Measles Appears in Your Community
Despite high vaccination rates in the United States, measles outbreaks still occur, typically when the virus is imported by travelers from countries where measles remains endemic. When a case is identified in your community, public health officials launch a coordinated response to prevent further spread.
As a parent, understanding this process can help you navigate the situation calmly and effectively if your family is affected.
Responding to Possible Exposure
How Exposure Is Defined
In healthcare settings, measles exposure is defined as: • Spending any time in a shared airspace with an infectious measles patient, or • Being in a space up to 2 hours after an infectious patient has left
The measles virus can remain suspended in the air for up to 2 hours after an infected person leaves an area, making it possible to contract the disease without direct contact with an infected individual.
If Your Child Has Been Exposed
If your child has been exposed to measles, what happens next depends on their vaccination status and immune function:
For Fully Vaccinated Children (2 doses of MMR) • No additional measures are typically needed • The risk of developing measles is very low (about 3%) • Monitor for symptoms for 21 days after exposure
For Unvaccinated or Partially Vaccinated Children Two interventions may be recommended, depending on timing:
Post-exposure vaccination (if within 72 hours of exposure) • MMR vaccine can provide protection if administered within 72 hours • This can prevent or modify the disease course • Even if it doesn't prevent disease in this instance, it will protect against future exposures
Immune globulin (if within 6 days of exposure) • For children who cannot receive the vaccine (e.g., infants under 6 months, pregnant individuals, severely immunocompromised patients) • Must be administered within 6 days of exposure • Can prevent or modify the severity of measles • Available as intramuscular (IGIM) or intravenous (IGIV) formulations
Special Considerations for High-Risk Groups
Infants Under 12 Months • Too young for routine vaccination • May receive MMR vaccine if exposure occurs after 6 months of age (within 72 hours of exposure) • Otherwise, immune globulin is recommended
Pregnant Women Without Immunity • Should receive intravenous immune globulin (IGIV) • Measles during pregnancy can lead to premature labor, low birth weight, and maternal complications
Immunocompromised Patients • Should receive IGIV regardless of vaccination history • At higher risk for severe disease and complications • This includes patients with:
Severe primary immunodeficiency
Recent hematopoietic cell transplants
Acute lymphoblastic leukemia treatment
Solid organ transplants
Severe HIV infection
Infants whose mothers received certain biologic response modifiers during pregnancy
Children Living with HIV • Recommendations depend on immune status and vaccination history • Those with no to moderate immunosuppression who have received 2 doses of vaccine after starting antiretroviral therapy typically don't need additional measures • Those with severe immunosuppression should receive IGIV
If Your Child Develops Measles: Treatment Options
Unlike many other viral illnesses, there is no specific antiviral therapy approved for measles. Treatment focuses on supportive care and preventing complications:
Supportive Care • Managing fever and discomfort with appropriate medications • Ensuring adequate hydration and nutrition • Monitoring for and promptly treating secondary bacterial infections
Vitamin A Supplementation
The World Health Organization and many U.S. experts recommend vitamin A supplementation for all children with measles, regardless of nutritional status. Vitamin A treatment has been associated with decreased morbidity and mortality, especially in children with vitamin A deficiency.
Recommended dosages are: • 200,000 IU for children 12 months or older • 100,000 IU for infants 6-11 months • 50,000 IU for infants younger than 6 months
This dose is given once daily for two days (immediately upon diagnosis and the following day). A third dose may be recommended 2-6 weeks later for children showing signs of vitamin A deficiency.
Other Treatments
For severe cases, especially in immunocompromised patients, physicians may consider: • Ribavirin (though not FDA-approved for this use) • Available through an emergency investigational new drug application • Has shown some effect in laboratory studies but lacks controlled clinical trials
Isolation and Preventing Spread
If your child is diagnosed with measles, preventing transmission to others is crucial:
Home Isolation • Keep your child at home for at least 4 days after the rash appears • For immunocompromised children, isolation may need to continue for the duration of illness • Family members who lack immunity should avoid contact if possible or receive post-exposure prophylaxis
School and Child Care Settings • Notify your child's school or child care center immediately • Public health officials will provide guidance on exclusion periods • Unvaccinated contacts may be excluded from school for up to 21 days after exposure
The Healthcare Response to Suspected Measles
When a healthcare provider suspects measles, a careful process is followed to prevent further spread while confirming the diagnosis:
Pre-Visit Telephone Triage • Patients reporting measles symptoms are assessed for risk factors • Questions about recent travel, community outbreaks, and vaccination status help gauge likelihood • Special arrival instructions are provided to minimize exposure to others
Office Precautions • Patients with suspected measles receive face masks before entering (for children 2 years and older) • Immediate isolation in a private room, ideally with special air handling capabilities • Only healthcare workers with documented immunity to measles provide care • Standard and airborne precautions are implemented, including N95 respirators for staff
Diagnostic Testing • Throat swabs and blood samples are collected for laboratory confirmation • Testing is typically coordinated with state public health laboratories • Results help determine subsequent public health actions
The Public Health Response
A single measles case triggers an immediate public health response because of the disease's extreme contagiousness:
Case Investigation • Interviewing the patient or family to determine infectious period and possible exposures • Identifying all potential contacts during the infectious period • Verifying vaccination status of exposed individuals
Contact Tracing • Notifying all identified contacts of their exposure • Assessing immune status of contacts • Recommending appropriate post-exposure prophylaxis • Monitoring contacts for 21 days after exposure
Vaccination Campaigns • During outbreaks, public health officials may organize vaccination clinics • May recommend accelerated vaccination schedules in affected communities • Educational outreach to increase awareness and vaccine acceptance
Public Notifications • Alerts to healthcare providers to increase vigilance • Public announcements about potential exposure locations • Clear guidance on symptoms and when to seek medical care
Healthcare Personnel Considerations
Healthcare workers play a crucial role in both detecting measles cases and preventing transmission in medical settings:
Immunity Requirements All healthcare personnel should have presumptive evidence of immunity to measles, including: • Documentation of two doses of MMR vaccine • Laboratory evidence of immunity • Laboratory confirmation of previous disease • Birth before 1957 (though during outbreaks, this group may need additional documentation)
After Workplace Exposure For healthcare workers exposed to measles: • Those with immunity: No work restrictions, but daily monitoring for symptoms for 21 days • Those without immunity: Exclusion from work from day 5 after first exposure through day 21 after last exposure • Those who develop measles: Exclusion from work for 4 days after rash appears (longer for immunocompromised workers)
The Global Picture and Future Challenges
While the United States has maintained measles elimination status (except for limited periods), global challenges remain:
• The COVID-19 pandemic disrupted routine vaccination worldwide • Decreased surveillance capacity has hampered early detection • Vaccine hesitancy continues to create pockets of vulnerability • International travel means continued risk of importation
These factors underscore the importance of maintaining high vaccination coverage and remaining vigilant, even in countries where measles is rarely seen.
Key Takeaways for Parents
As we conclude our series on measles, here are the essential points to remember:
Vaccination remains our best defense against measles, with two doses providing approximately 97% protection
Community immunity requires high vaccination rates (92-94%) to prevent outbreaks
Early action after exposure can prevent or modify disease through vaccination or immune globulin
Recognize the symptoms of measles—high fever, the three Cs (cough, coryza, conjunctivitis), and a distinctive rash
Call ahead before seeking medical care if you suspect measles to allow for proper infection control measures
Public health measures protect everyone, especially those who cannot be vaccinated
By understanding measles—its symptoms, prevention, and management—parents can make informed decisions to protect their children and contribute to keeping this once-common disease a rarity in our communities.
If you have questions about measles or vaccination, speak with your healthcare provider or contact your local health department. Ensuring your family is up-to-date on recommended vaccines is one of the most effective ways to protect against preventable diseases.
Interested in learning more? Download our app on IOS and Android!
